Laszlo, G. S., Beddoe, M. E., Godwin, C. D., Bates, O. M., Gudgeon, C. J., Harrington, K. H., & Walter, R. B. (2019). Relationship between CD33 expression, splicing polymorphism, and in vitro cytotoxicity of gemtuzumab ozogamicin and the CD33/CD3 BiTE® AMG 330. Haematologica.

Laszlo, George S., Mary E. Beddoe, Colin D. Godwin, Olivia M. Bates, Chelsea J. Gudgeon, Kimberly H. Harrington, and Roland B. Walter. "Relationship between CD33 Expression, Splicing Polymorphism, and in Vitro Cytotoxicity of Gemtuzumab Ozogamicin and the CD33/CD3 BiTE® AMG 330." Haematologica 2019.

Laszlo, George S., et al. "Relationship between CD33 Expression, Splicing Polymorphism, and in Vitro Cytotoxicity of Gemtuzumab Ozogamicin and the CD33/CD3 BiTE® AMG 330." Haematologica 2019.